Literature DB >> 3298850

Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritis.

G T Westermark, P Westermark, K Sletten.   

Abstract

Protein AA, the main fibril protein in secondary systemic amyloidosis, is a mixture of protein fragments (subspecies) of different length, probably arising by enzymatic cleavage of a serum precursor, SAA. We have purified amyloid fibril protein AA from a patient with rheumatoid arthritis and secondary amyloidosis with an unusual amyloid distribution in organs. This protein AA contained two major subspecies of which one consisted of 50 amino acid residues shown by complete amino acid sequence analysis. The other major AA subspecies, characterized by N- and C-terminal sequence analysis and amino acid determination of proteolytic peptides, contained 45 amino acid residues. The pI of these AA-variants differed considerably, 8.1 to 5.5, respectively. Several minor protein AA subspecies were also identified, among them one with a blocked N-terminal. The findings indicate that AA proteins of different length are connected to varying AA amyloid syndromes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298850

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Senile aortic amyloid. Evidence for two distinct forms of localized deposits.

Authors:  G Mucchiano; G G Cornwell; P Westermark
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

2.  Age-related accumulation of amyloid inclusions in adrenal cortical cells.

Authors:  L Eriksson; P Westermark
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

3.  Amyloid deposition in the digestive tract in casein-induced experimental amyloidosis in mice.

Authors:  Y Kobayashi; Y Shimada; K Terasawa
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

4.  AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.

Authors:  G T Westermark; K Sletten; A Grubb; P Westermark
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosis.

Authors:  B Norling; G T Westermark; P Westermark
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

6.  Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.

Authors:  M M Silver; S A Hearn; J C Walton; L A Lines; V M Walley
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.

Authors:  C Röcken; R Menard; F Bühling; S Vöckler; J Raynes; B Stix; S Krüger; A Roessner; T Kähne
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

Review 8.  Currents concepts on the immunopathology of amyloidosis.

Authors:  Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

9.  Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient.

Authors:  F E Dische; C Wernstedt; G T Westermark; P Westermark; M B Pepys; J A Rennie; S G Gilbey; P J Watkins
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

10.  Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.

Authors:  G T Westermark; B Norling; P Westermark
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.